ARS Pharmaceuticals annual operating margin
2021
2022
2023
2024
2025
ARS Pharmaceuticals's operating margin was −212.92% for fiscal 2025.
View full ARS Pharmaceuticals company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −212.92% | −209.47 pp |
| 2024 | 2024-12-31 | −3.46% | +225063.21 pp |
| 2023 | 2023-12-31 | −225,066.67% | −222367.88 pp |
| 2022 | 2022-12-31 | −2,698.78% | −2345.46 pp |
| 2021 | 2021-12-31 | −353.32% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −182.62% | +120.33 pp |
| Q1 2026 | 2026-03-31 | −265.18% | +201.11 pp |
| Q4 2025 | 2025-12-31 | −147.63% | −202.14 pp |
| Q3 2025 | 2025-09-30 | −163.66% | +887.98 pp |
| Q2 2025 | 2025-06-30 | −302.95% | +2765.05 pp |
| Q1 2025 | 2025-03-31 | −466.29% | +205563.71 pp |
| Q4 2024 | 2024-12-31 | 54.51% | +93619.51 pp |
| Q3 2024 | 2024-09-30 | −1,051.64% | +2456.29 pp |
| Q2 2024 | 2024-06-30 | −3,068.00% | −1700.76 pp |
| Q2 2023 | 2023-06-30 | −206,030.00% | −204959.26 pp |
| Q1 2023 | 2023-03-31 | −93,565.00% | — |
| Q3 2022 | 2022-09-30 | −3,507.94% | — |
| Q2 2022 | 2022-06-30 | −1,367.24% | — |
| Q1 2022 | 2022-03-31 | −1,070.74% | — |
Across the available reported history, ARS Pharmaceuticals's operating margin decreased from −3.46% to −212.92%, a change of −209.47 percentage points. The latest reported quarter, Q2 2026, shows −182.62%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ARS Pharmaceuticals filings at SEC.gov ↗